We are pleased to announce that Dr. Jörg Taubel, will be one of the faculty members at the upcoming course tailored for postgraduates in life sciences interested in early clinical development of medicinal products.

This comprehensive course consists of two parts, spanning several days, providing an in-depth overview of Human Pharmacology and Translational Medicine. The curriculum covers essential topics from non-clinical pharmacology and toxicology to first-in-man studies and proof-of-concept clinical trials.

To find out more, click here:

Latest news

Accelerated Pathways: How ILAP Gives Developers a Strategic Early Advantage

January 29, 2026
The pace of medical innovation is faster than ever, but patients often face delays in accessing transformative therapies.
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event